TY  - JOUR
AU  - Martín-Blázquez, Ariadna
AU  - Jiménez-Luna, Cristina
AU  - Díaz, Caridad
AU  - Martínez-Galán, Joaquina
AU  - Prados, Jose
AU  - Vicente, Francisca
AU  - Melguizo, Consolación
AU  - Genilloud, Olga
AU  - Pérez Del Palacio, José
AU  - Caba, Octavio
PY  - 2020
DO  - 10.3390/cancers12041002
SN  - 2072-6694
UR  - https://hdl.handle.net/10668/28183
T2  - Cancers
AB  - Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal cancers, with a 5-year survival rate of less than 5%. In fact, complete surgical resection remains the only curative treatment. However, fewer than 20% of patients are...
LA  - en
KW  - biomarker
KW  - diagnosis
KW  - metabolomics
KW  - pancreatic ductal adenocarcinoma
KW  - reverse-phase liquid chromatography
TI  - Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics.
TY  - research article
VL  - 12
ER  -